PURPOSE: Attempts to improve survival of patients with esophageal cancer have been made using induction chemoradiotherapy (CRT) followed by surgery. A large single-center experience was reviewed to determine which treatment-related variables could predict survival and recurrence. PATIENTS AND METHODS: All patients undergoing esophagectomy between January 1994 and December 2002 were reviewed. Univariate and multivariate analyses were performed using log-rank and Cox proportional hazards models, and survival curves were estimated using the Kaplan-Meier method. RESULTS: Of 171 patients with invasive cancer, 131 (77%) underwent preoperative CRT. The average age was 60 years, and most patients were male (85%). Operations performed included Ivor-Lewis (60%), transhiatal (8%), three-hole (23%), or left thoracoabdominal (8%) esophagectomy. Perioperative mortality rate was 5%. Median overall survival (OS) of the entire group was 33 months, and the 5-year OS rate was 26%. Induction CRT was associated with a 33% 5-year survival rate compared with 11% for surgery alone (P = .43). Patients downstaged to pathologic stage 0 or I had an improved OS and disease-free survival (DFS) compared with those patients who were not downstaged (P = .022). Additionally, the ability to perform an R0 resection was a significant factor for OS and DFS (n = 130; P < .0001 and P <.0002, respectively). CONCLUSION: Response to CRT and the ability to perform an R0 resection are associated with significantly improved survival in patients with esophageal carcinoma.
PURPOSE: Attempts to improve survival of patients with esophageal cancer have been made using induction chemoradiotherapy (CRT) followed by surgery. A large single-center experience was reviewed to determine which treatment-related variables could predict survival and recurrence. PATIENTS AND METHODS: All patients undergoing esophagectomy between January 1994 and December 2002 were reviewed. Univariate and multivariate analyses were performed using log-rank and Cox proportional hazards models, and survival curves were estimated using the Kaplan-Meier method. RESULTS: Of 171 patients with invasive cancer, 131 (77%) underwent preoperative CRT. The average age was 60 years, and most patients were male (85%). Operations performed included Ivor-Lewis (60%), transhiatal (8%), three-hole (23%), or left thoracoabdominal (8%) esophagectomy. Perioperative mortality rate was 5%. Median overall survival (OS) of the entire group was 33 months, and the 5-year OS rate was 26%. Induction CRT was associated with a 33% 5-year survival rate compared with 11% for surgery alone (P = .43). Patients downstaged to pathologic stage 0 or I had an improved OS and disease-free survival (DFS) compared with those patients who were not downstaged (P = .022). Additionally, the ability to perform an R0 resection was a significant factor for OS and DFS (n = 130; P < .0001 and P <.0002, respectively). CONCLUSION: Response to CRT and the ability to perform an R0 resection are associated with significantly improved survival in patients with esophageal carcinoma.
Authors: Patrick J McLaren; Nathan W Bronson; Kyle D Hart; Gina M Vaccaro; Ken M Gatter; Charles R Thomas; John G Hunter; James P Dolan Journal: J Gastrointest Surg Date: 2017-01-12 Impact factor: 3.452
Authors: Arianna Barbetta; Tamar B Nobel; Smita Sihag; Meier Hsu; Kay See Tan; Manjit S Bains; James M Isbell; Yelena Y Janjigian; Abraham J Wu; Matthew J Bott; David R Jones; Daniela Molena Journal: Ann Thorac Surg Date: 2018-05-05 Impact factor: 4.330
Authors: Eugene Y Chang; Xin Li; Michael Jerosch-Herold; Ryan A Priest; C Kristian Enestvedt; Jingang Xu; Charles S Springer; Blair A Jobe Journal: J Gastrointest Surg Date: 2007-09-01 Impact factor: 3.452
Authors: Faisal A Siddiqui; Katelyn M Atkins; Brian S Diggs; Charles R Thomas; John G Hunter; James P Dolan Journal: J Gastrointest Oncol Date: 2014-04
Authors: Nastaran Neishaboori; Roopma Wadhwa; Graciela M Nogueras-González; Elena Elimova; Hironori Shiozaki; Kazuki Sudo; Nikolaos Charalampakis; Adarsh Hiremath; Jeffrey H Lee; Manoop S Bhutani; Brian Weston; Mariela A Blum; Jane E Rogers; Jeana L Garris; David C Rice; Ritsuko Komaki; Stephen G Swisher; Heath D Skinner; Wayne L Hofstetter; Jaffer A Ajani Journal: Oncology Date: 2015-03-05 Impact factor: 2.935
Authors: Peter G Rose; James J Java; Mark A Morgan; Angeles Alvarez-Secord; Joshua P Kesterson; Frederick B Stehman; David P Warshal; William T Creasman; Parviz Hanjani; Robert T Morris; Larry J Copeland Journal: Gynecol Oncol Date: 2016-09-28 Impact factor: 5.482